These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 21658861

  • 21. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M, Fernández M, Morcillo-Suárez C, Navarro A, Julià E, Edo MC, Montalban X, Comabella M.
    J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
    [Abstract] [Full Text] [Related]

  • 22. A study of promoter and intronic markers of ApoI/Fas gene and the interaction with Fas ligand in relapsing multiple sclerosis.
    Lucas M, Zayas MD, De Costa AF, Solano F, Chadli A, Dinca L, Izquierdo G.
    Eur Neurol; 2004 May; 52(1):12-7. PubMed ID: 15218339
    [Abstract] [Full Text] [Related]

  • 23. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
    Kroner A, Grimm A, Johannssen K, Mäurer M, Wiendl H.
    Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
    [Abstract] [Full Text] [Related]

  • 24. Lack of association between paraoxonase 1 Q192R polymorphism and multiple sclerosis in relapse phase: A case-control study.
    Moghtaderi A, Hashemi M, Sharafaddinzadeh N, Dabiri S, Moazeni-Roodi A, Ramroodi N, Zolfaghari M.
    Clin Biochem; 2011 Jul; 44(10-11):795-8. PubMed ID: 21545792
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.
    Liguori M, Fera F, Gioia MC, Valentino P, Manna I, Condino F, Cerasa A, La Russa A, Clodomiro A, Paolillo A, Nisticò R, Vercillo L, Cittadella R, Quattrone A.
    Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142
    [Abstract] [Full Text] [Related]

  • 27. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.
    Schrijver HM, van As J, Crusius JB, Dijkstra CD, Uitdehaag BM.
    Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358
    [Abstract] [Full Text] [Related]

  • 28. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group.
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chemokine receptor CCR5 in interferon-treated multiple sclerosis.
    Sellebjerg F, Kristiansen TB, Wittenhagen P, Garred P, Eugen-Olsen J, Frederiksen JL, Sørensen TL.
    Acta Neurol Scand; 2007 Jun; 115(6):413-8. PubMed ID: 17511851
    [Abstract] [Full Text] [Related]

  • 31. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
    Achiron A, Gurevich M, Snir Y, Segal E, Mandel M.
    Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
    [Abstract] [Full Text] [Related]

  • 32. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP.
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
    Ganesvaran G, Greer JM, Pender MP.
    Mult Scler; 2009 Jun; 15(6):763-6. PubMed ID: 19482865
    [Abstract] [Full Text] [Related]

  • 35. NOS2A as a candidate gene in Relapsing-Remitting Multiple Sclerosis: a haplotype study using selected subsets of single nucleotide polymorphisms.
    Manna I, Liguori M, Valentino P, Vena L, Condino F, Nisticò R, Di Palma G, Quattrone A, Gambardella A.
    J Neurol Sci; 2011 May 15; 304(1-2):75-7. PubMed ID: 21376344
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
    Stojković L, Djurić T, Stanković A, Dinčić E, Stančić O, Veljković N, Alavantić D, Zivković M.
    J Neuroimmunol; 2012 Apr 15; 245(1-2):87-92. PubMed ID: 22261545
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients.
    Ristić S, Lovrecić L, Starcević-Cizmarević N, Brajenović-Milić B, Jazbec SS, Barac-Latas V, Vejnović D, Sepcić J, Kapović M, Peterlin B.
    Mult Scler; 2006 Jun 15; 12(3):360-2. PubMed ID: 16764352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.